scispace - formally typeset
G

Gianluca Bartolucci

Researcher at University of Florence

Publications -  143
Citations -  2811

Gianluca Bartolucci is an academic researcher from University of Florence. The author has contributed to research in topics: Medicine & Carbonic anhydrase. The author has an hindex of 26, co-authored 117 publications receiving 2103 citations. Previous affiliations of Gianluca Bartolucci include ARPA-E & International Military Sports Council.

Papers
More filters
Journal ArticleDOI

Sponge-associated microbial Antarctic communities exhibiting antimicrobial activity against Burkholderia cepacia complex bacteria.

TL;DR: The whole body of data obtained in this work indicates that sponge-associated bacteria represent an untapped source for the identification of new antimicrobial compounds and are paving the way for the discovery of new drugs that can be efficiently and successfully used for the treatment of CF infections.
Journal ArticleDOI

Design and Synthesis of Novel Nonsteroidal Anti-Inflammatory Drugs and Carbonic Anhydrase Inhibitors Hybrids (NSAIDs-CAIs) for the Treatment of Rheumatoid Arthritis.

TL;DR: A series of hybrid compounds incorporating 6- and 7-substituted coumarins derivatized with clinically used NSAIDs as agents for the management of rheumatoid arthritis showed potent and persistent antihyperalgesic effect up to 60 min after administration.
Journal ArticleDOI

Dominulin A and B : Two new antibacterial peptides identified on the cuticle and in the venom of the social paper wasp Polistes dominulus using MALDI-TOF, MALDI-TOF/TOF, and ESI-ion trap

TL;DR: Two new antibacterial peptides, denominated as Dominulin A and B, have been found on the cuticle and in the venom of females of the social paper wasp Polistes dominulus, suggesting their classification in the mastoparans, a class of peptides found in the Venom of other Aculeate hymenoptera.
Journal ArticleDOI

Ranolazine Prevents Phenotype Development in a Mouse Model of Hypertrophic Cardiomyopathy.

TL;DR: Owing to the sustained reduction of intracellular Ca2+ and calmodulin kinase activity, ranolazine prevented the development of morphological and functional cardiac phenotype in mice carrying a clinically relevant HCM-related mutation.